Change in Quality of Life in Patients with Advanced Rectal Cancer Between 2010 and 2022
View abstract on PubMed
Summary
This summary is machine-generated.Quality of life for rectal cancer patients worsened over time, particularly in social functioning and role functioning. This decline is linked to societal factors, not solely cancer treatment side effects.
Area Of Science
- Oncology
- Public Health
- Patient-Reported Outcomes
Background
- Advanced rectal cancer is a significant global health concern.
- Multimodal therapy has improved survival, making quality of life a critical factor.
- Understanding long-term patient well-being is essential for comprehensive cancer care.
Purpose Of The Study
- To assess health-related quality of life (HRQoL) in rectal cancer patients from 2010 to 2022.
- To identify changes in functioning and symptom scores over time.
- To evaluate the impact of treatment and societal factors on long-term HRQoL.
Main Methods
- Longitudinal study of 516 rectal cancer patients at University Hospital Erlangen, Germany (13-year period).
- Utilized the EORTC QLQ-C30 and QLQ-CR38 questionnaires for HRQoL assessment.
- Collected data pre-treatment, during treatment, and at annual follow-ups; statistical significance set at p<0.05 or a 10% difference.
Main Results
- Immediate post-treatment decline in pain, fatigue, and diarrhea scores.
- One year post-therapy, most scores normalized, but role/social functioning and diarrhea remained significantly worse.
- Over the study period (2010-2022), role functioning, social functioning, body image, fatigue, and nausea showed clear deterioration.
Conclusions
- No significant improvement in therapy-related side effects or quality of life was demonstrated over time.
- Deterioration in patient-reported outcomes appears linked to broader societal or healthcare factors, not exclusively oncological disease progression or treatment.
- Further research is needed to address systemic influences on long-term patient well-being in advanced rectal cancer.
Related Concept Videos
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Evaluating the rectum and anus plays a crucial role in conducting a thorough physical examination of the gastrointestinal system. Although it may be uncomfortable and often embarrassing for the patient, it holds immense diagnostic value, particularly in detecting gastrointestinal diseases and abnormalities. This guide will explain how to perform this assessment using inspection and palpation methods.
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

